# FDA Inspection 1223757 - Clinigen Inc. - November 14, 2023

Source: https://www.globalkeysolutions.net/records/fda_inspections/clinigen-inc/ffcedff8-62c4-447b-9b6a-770b98eb8d9a/
Source feed: FDA_Inspections

> FDA Inspection 1223757 for Clinigen Inc. on November 14, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1223757
- Company Name: Clinigen Inc.
- Inspection Date: 2023-11-14
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1223757 - 2023-11-14](https://www.globalkeysolutions.net/api/records/fda_inspections/clinigen-inc/d181b8be-bf70-47ad-a962-da6fcbae1be9/)
- [FDA Inspection 995376 - 2016-10-26](https://www.globalkeysolutions.net/api/records/fda_inspections/clinigen-inc/9bfa7be8-4c10-44d6-9b16-25b1e4b1f401/)

Company: https://www.globalkeysolutions.net/companies/clinigen-inc/ff7f734b-58bd-41a4-bb0b-b8f62f8d37ff

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d